Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 109
Selected: 0
NCT IDTitle
NCT03236428Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma
NCT04407442Daratumumab, Azacitidine, and Dexamethasone for Treatment of Patients With Recurrent or Refractory Multiple Myeloma Previously Treated With Daratumumab
NCT03475628Effects of Daratumumab Monotherapy on Bone Parameters in Patients With Relapsed and /or Refractory Multiple Myeloma
NCT00001018A Study of Letrazuril in the Treatment of AIDS-Related Diarrhea
NCT03503344Apalutamide With or Without Stereotactic Body Radiation in Treating Castration-Resistant Prostate Cancer
NCT06396533Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE)
NCT02002130The Use of Glutamic Acid Decarboxylase (GAD) and Gamma-Amino Butyric Acid (GABA) in the Treatment of Type I Diabetes
NCT02772588AASUR in High Risk Prostate Cancer
NCT03655223Early Check: Expanded Screening in Newborns
NCT06083922A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
NCT03397186Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma
NCT05896748Study to Assess the Effects of Cabotegravir (CAB) and Rilpivirine (RPV) Long-Acting (LA) Injections Following Sub-cutaneous (SC) Administration Compared With Intramuscular (IM) Administration in Adult Participants Living With Human Immunodeficiency Virus (HIV-1) Infection in the FLAIR Study
NCT05109559Ad26.COV2.S as a Heterologous Booster in Adults After Single- or Two-Dose of Inactivated COVID-19 Vaccine
NCT00167154Risperidone and Suicidality in Major Depressive Disorder
NCT01236391Safety and Efficacy of PCI-32765 in Participants With Relapsed/Refractory Mantle Cell Lymphoma (MCL)
NCT01717053Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate Cancer
NCT01905059Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa
NCT01241760VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection
NCT017514513-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy
NCT02438631Placental Passage and Disposition of Drugs: A Physiology-based Approach
NCT01837862A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
NCT03696160The Late Presenter Treatment Optimisation Study
NCT00140426A Double-blind, Placebo Controlled Trial of Risperidone for the Treatment of Anorexia Nervosa
NCT06856902BEhavioral and Adherence Model for Improving Quality, Health Outcomes and Cost-Effectiveness of healthcaRe
NCT05826756Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting
NCT06549634Biomarkers of AKI in Patients Receiving Daratumumab
NCT07110844Teclistamab-Daratumumab in AL Amyloidosis
NCT03283917Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis
NCT02841033Daratumumab for the Treatment of Patients With AL Amyloidosis
NCT00222807Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus
NCT02838693Assessing Progression to Type-2 Diabetes (APT-2D): A Prospective Cohort Study Expanded From BRITE-SPOT (Bio-bank and Registry for StratIfication and Targeted intErventions in the Spectrum Of Type 2 Diabetes)
NCT04399551A Study Evaluating Implementation Strategies for Cabotegravir (CAB)+ Rilpivirine (RPV) Long-acting (LA) Injectables for Human Immunodeficiency Virus (HIV)-1 Treatment in European Countries
NCT05619536Study of CD388 Subcutaneous Administration in Healthy Japanese Subjects
NCT03522259Rivaroxaban as Thrombosis Prophylaxis in Bariatric Surgery
NCT00404989Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.
NCT06066346A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
NCT04162366A Research Study to Show Aprocitentan is Efficacious and Safe to Treat Patients With Uncontrolled Blood Pressure and Chronic Kidney Disease.
NCT04116606Antidepressant Trial With P2X7 Antagonist JNJ-54175446
NCT01947920A Dose Ranging Escalation Study of Tramadol Hydrochloride in Healthy Volunteers
NCT00277654Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder
NCT04089345Stelara fOr ChRonic AntibioTic rEfractory pouchitiS
NCT02867020Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levels
NCT03404635Monotherapy Anticoagulation To Expedite Home Treatment of Venous Thromboembolism
NCT00855413HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine
NCT00002132Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis.
NCT01376401Bendamustine, Bortezomib (Velcade ®) and Prednisone (BVP) in Patients Newly Diagnosed Multiple Myeloma
NCT03586570A Study to Evaluate How Aprocitentan is Safe and How it is Absorbed and Broken Down in the Body of Japanese and Caucasian Subjects
NCT02373930Relative Oral Bioavailability Study of Different Fixed Dose Combinations of Dolutegravir and Rilpivirine in Healthy Subjects
NCT01054573VX-950-TiDP24-C219: A Roll Over Trial for Patients in the Control Group of the C216 Study Who Received Telaprevir Placebo
NCT04268498A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma